Literature DB >> 1105061

The nude mouse: a model of deficient T-cell function.

M Pelleitier, S Montplaisir.   

Abstract

Congenitally athymic nude mice (nu/nu) are presented as a model for the study of cell-mediated immunologic deficiencies. These mice possess a vestigial thymus which is incapable of producing mature T-cells as shown by a decreased lymphocyte population carrying the theta antigen and depleted 'thymus-dependent' areas in their peripheral lymphoid organs. However, they have T-cell precursors in their bone marrow. Nude mice lack 'thymosin', a thymic factor secreted by the epithelial cells of the thymus. They also have impaired T-cell functions as demonstrated by an absence of delayed hypersensitivity reactions, an inability to reject skin allografts and a decreased antibody response to some T-dependent antigens. But their response to T-independent antigens is normal. The presence of circulating auto-antibodies and immune-complex type glomerulonephritis in nude mice reinforces the hypothesis that spontaneous autoimmunity and B-cell hyperactivity are associated with T-cell deficiency. On the other hand, they are not especially susceptible to spontaneous tumor development. Correlations are made between the pathologic findings in nude mice and some congenital cellular immunologic disorders in man.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1105061

Source DB:  PubMed          Journal:  Methods Achiev Exp Pathol        ISSN: 0076-681X


  41 in total

Review 1.  Xenografting of testicular tissue pieces: 12 years of an in vivo spermatogenesis system.

Authors:  Lucía Arregui; Ina Dobrinski
Journal:  Reproduction       Date:  2014-08-22       Impact factor: 3.906

2.  Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression.

Authors:  Alexandra G Fraga; Andrea Cruz; Teresa G Martins; Egídio Torrado; Margarida Saraiva; Daniela R Pereira; Wayne M Meyers; Françoise Portaels; Manuel T Silva; António G Castro; Jorge Pedrosa
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

3.  Plasmid DNA vaccine-elicited cellular immune responses limit in vivo vaccine antigen expression through Fas-mediated apoptosis.

Authors:  John R Greenland; Ralf Geiben; Sharmistha Ghosh; William A Pastor; Norman L Letvin
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

4.  Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain.

Authors:  Y Koyanagi; Y Tanaka; J Kira; M Ito; K Hioki; N Misawa; Y Kawano; K Yamasaki; R Tanaka; Y Suzuki; Y Ueyama; E Terada; T Tanaka; M Miyasaka; T Kobayashi; Y Kumazawa; N Yamamoto
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 5.  Searching for genes involved in the pathogenesis of primary immunodeficiency diseases: lessons from mouse knockouts.

Authors:  C M Kokron; F A Bonilla; H C Oettgen; N Ramesh; R S Geha; F Pandolfi
Journal:  J Clin Immunol       Date:  1997-03       Impact factor: 8.317

6.  Temporal characterization of lymphatic metastasis in an orthotopic mouse model of oral cancer.

Authors:  Peter Szaniszlo; Susan M Fennewald; Suimin Qiu; Carla Kantara; Tuya Shilagard; Gracie Vargas; Vicente A Resto
Journal:  Head Neck       Date:  2014-01-27       Impact factor: 3.147

7.  Histoplasma capsulatum infection in nude mice.

Authors:  D M Williams; J R Graybill; D J Drutz
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

8.  Histopathological studies on experimental cryptococcosis in nude mice.

Authors:  K Nishimura; M Miyaji
Journal:  Mycopathologia       Date:  1979-09-28       Impact factor: 2.574

9.  Mouse orthotopic lung cancer model induced by PC14PE6.

Authors:  Zheng Yun Cui; Jin Seok Ahn; Jee Yun Lee; Won Seog Kim; Ho Yeong Lim; Hyun Jung Jeon; Soo Won Suh; Jin Hoon Kim; Won Ho Kong; Ji Min Kang; Do Hyun Nam; Keunchil Park
Journal:  Cancer Res Treat       Date:  2006-12-31       Impact factor: 4.679

10.  Preclinical pharmacology of BA-TPQ, a novel synthetic iminoquinone anticancer agent.

Authors:  Scharri J Ezell; Haibo Li; Hongxia Xu; Xiangrong Zhang; Evrim Gurpinar; Xu Zhang; Elizabeth R Rayburn; Charnell I Sommers; Xinyi Yang; Sadanandan E Velu; Wei Wang; Ruiwen Zhang
Journal:  Mar Drugs       Date:  2010-07-13       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.